Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies

Fabio Bertoni and Tereza Tykvova

Post-Print from HAL

Abstract: This paper explores whether and how governmental venture capital investors (GVCs) spur invention and innovation in young biotech companies in Europe. To gauge invention we focus on the simple patent stock at the company level, while innovation is proxied by the citation-weighted patent stock. Our findings indicate that GVCs, as stand-alone investors, have no impact on invention and innovation. However, GVCs boost the impact of independent venture capital investors (IVCs) on both invention and innovation. We conclude that GVCs are an ineffective substitute, but an effective complement, of IVCs. We also distinguish between technology-oriented GVCs (TVCs) and development-oriented GVCs (DVCs). We find that DVCs are better at increasing firm's inventions, and that TVCs, combined with IVCs, support innovations.

Keywords: Governmental venture capital; Independent venture capital; Patenting; Invention; Innovation; Biotechnology (search for similar items in EconPapers)
Date: 2015-05-01
References: Add references at CitEc
Citations: View citations in EconPapers (88)

Published in Research Policy, 2015, 44 (4), 925-935 p. ⟨10.1016/j.respol.2015.02.002⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Journal Article: Does governmental venture capital spur invention and innovation? Evidence from young European biotech companies (2015)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02313268

DOI: 10.1016/j.respol.2015.02.002

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().